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Background: Long term angioscopic follow-up comparison between sirolimus-eluting (SES) and paclitaxel-eluting stent (PES) has not been 
examined yet.
Methods: Forty-three SES and 40 PES, and 18 SES and 23 PES were successfully assessed using coronary angioscopy at 6 and 18-month follow-
up, respectively. We evaluated the incidence of mural thrombus, minimum neointimal coverage grade, and maximum one within one stent using the 
following neointimal coverage grade: 0: no neointimal coverage of stent struts, 1: very thin coverage, 2: between 1 and 3, and 3: invisible stent struts 
with full neointimal coverage. Temporal changes of angioscopic parameters were evaluated and compared in each stent groups, and the results were 
also compared between SES and PES groups.
Results: As shown in the table, PES showed regressive minimum neointimal coverage grade and remained relatively high thrombogenicity from 6 to 
18-month, while SES showed progressive tendency of neointimal formation and relatively low thrombogenicity compared with PES. At 18 months after 
stent implantation, PES showed lower minimum neointimal coverage grade (0.70 ± 0.64 vs 1.33 ± 0.69, p=0.004) and higher thrombogenicity (70 
% vs 11 %, p<0.001) as compared with SES.
Conclusions: Temporal change of neointimal coverage is different between SES and PES. In addition, PES showed significantly higher 
thrombogenicity than SES at 18-month after stent implantation.
6 months 18 months p Value
Sirolimus-eluting stent n=43 n=18
Minimum grade 1.07 ± 0.46 1.33 ± 0.69 0.148
Maximum grade 1.86 ± 0.64 2.22 ± 0.73 0.058
Incidence of thrombus, n(%) 5 (12) 2 (11) 0.663
Paclitaxel-eluting stent n=40 n=23
Minimum grade 1.13 ± 0.65 0.70 ± 0.64 0.013
Maximum grade 2.40 ± 0.71 2.48 ± 0.73 0.678
Incidence of thrombus, n(%) 20 (50) 16 (70) 0.187
